How Are We Addressing Axial Psoriatic Arthritis in Clinical Practice?
Author
Date
2024-12Permanent link
https://hdl.handle.net/11351/12311DOI
10.1007/s40744-024-00722-w
ISSN
2198-6584
WOS
001335349000001
PMID
39422869
Abstract
Psoriatic arthritis (PsA) is a chronic inflammatory disease affecting the musculoskeletal system, skin and nails. In addition to peripheral joints, inflammation of the spine and sacroiliac joints may occur. Yet, research into this axial phenotype has lagged behind partly because of the challenge in its clinical identification with a lack of specific clinical, molecular or imaging biomarkers. In the absence of a validated definition of what constitutes axial PsA (axPsA), guidelines for the management of axial involvement in PsA in clinical practice are scarce. On the basis of a literature review and their clinical expertise, a group of rheumatology experts provide their opinion to aid the diagnosis and management of axial PsA in clinical practice.
Keywords
Psoriatic arthritis; Psoriatic spondylitis; SacroiliitisBibliographic citation
Michelena X, López-Medina C, De Miguel E, Moreno-Ramos MJ, Queiro R, Marzo-Ortega H, et al. How Are We Addressing Axial Psoriatic Arthritis in Clinical Practice? Rheumatol Ther. 2024 Dec;11:1441–56.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4476]
The following license files are associated with this item:





